JP2024534947A5 - - Google Patents
Info
- Publication number
- JP2024534947A5 JP2024534947A5 JP2024515041A JP2024515041A JP2024534947A5 JP 2024534947 A5 JP2024534947 A5 JP 2024534947A5 JP 2024515041 A JP2024515041 A JP 2024515041A JP 2024515041 A JP2024515041 A JP 2024515041A JP 2024534947 A5 JP2024534947 A5 JP 2024534947A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- pharmaceutical composition
- liquid pharmaceutical
- use according
- alpha
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21197120.5 | 2021-09-16 | ||
| EP21197120 | 2021-09-16 | ||
| PCT/EP2022/075402 WO2023041524A2 (en) | 2021-09-16 | 2022-09-13 | Compositions and methods for treating synucleinopathies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024534947A JP2024534947A (ja) | 2024-09-26 |
| JP2024534947A5 true JP2024534947A5 (https=) | 2025-09-05 |
Family
ID=78049153
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024515041A Pending JP2024534947A (ja) | 2021-09-16 | 2022-09-13 | シヌクレイノパチーを治療するための組成物及び方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (5) | US12077578B2 (https=) |
| EP (1) | EP4401770A2 (https=) |
| JP (1) | JP2024534947A (https=) |
| KR (1) | KR20240055758A (https=) |
| CN (1) | CN117915952A (https=) |
| AR (1) | AR127054A1 (https=) |
| AU (1) | AU2022348798A1 (https=) |
| CA (1) | CA3230055A1 (https=) |
| CL (2) | CL2024000753A1 (https=) |
| IL (1) | IL311344A (https=) |
| MX (1) | MX2024002970A (https=) |
| WO (1) | WO2023041524A2 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112018014281A2 (pt) * | 2016-11-15 | 2018-12-18 | H Lundbeck As | agentes, usos e métodos para o tratamento da sinucleinopatia |
| EP4401770A2 (en) * | 2021-09-16 | 2024-07-24 | H. Lundbeck A/S | Compositions and methods for treating synucleinopathies |
| CN121794293A (zh) * | 2023-09-14 | 2026-04-03 | 豪夫迈·罗氏有限公司 | 抗体制剂 |
| WO2025186235A1 (en) | 2024-03-05 | 2025-09-12 | H. Lundbeck A/S | Compositions and methods for treating multiple system atrophy (msa) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2361928T3 (pl) * | 2003-05-19 | 2017-09-29 | Prothena Biosciences Limited | Skrócone fragmenty alfa-synukleiny w chorobie z ciałami Lewy'ego |
| US10513555B2 (en) * | 2013-07-04 | 2019-12-24 | Prothena Biosciences Limited | Antibody formulations and methods |
| WO2016077687A1 (en) | 2014-11-14 | 2016-05-19 | Voyager Therapeutics, Inc. | Compositions and methods of treating amyotrophic lateral sclerosis (als) |
| GB201512203D0 (en) | 2015-07-13 | 2015-08-19 | Lundbeck & Co As H | Agents,uses and methods |
| WO2017176835A2 (en) * | 2016-04-06 | 2017-10-12 | Imago Pharmaceuticals, Inc. | Therapeutic antibodies for treatment of neurodegeneration |
| BR112018014281A2 (pt) * | 2016-11-15 | 2018-12-18 | H Lundbeck As | agentes, usos e métodos para o tratamento da sinucleinopatia |
| JOP20190227A1 (ar) * | 2017-03-31 | 2019-09-30 | Biogen Int Neuroscience Gmbh | تركيبات وطرق لعلاج اعتلالات السينوكلين |
| EP4401770A2 (en) | 2021-09-16 | 2024-07-24 | H. Lundbeck A/S | Compositions and methods for treating synucleinopathies |
-
2022
- 2022-09-13 EP EP22789489.6A patent/EP4401770A2/en active Pending
- 2022-09-13 IL IL311344A patent/IL311344A/en unknown
- 2022-09-13 JP JP2024515041A patent/JP2024534947A/ja active Pending
- 2022-09-13 MX MX2024002970A patent/MX2024002970A/es unknown
- 2022-09-13 CN CN202280060631.5A patent/CN117915952A/zh active Pending
- 2022-09-13 AU AU2022348798A patent/AU2022348798A1/en active Pending
- 2022-09-13 CA CA3230055A patent/CA3230055A1/en active Pending
- 2022-09-13 KR KR1020247008828A patent/KR20240055758A/ko active Pending
- 2022-09-13 WO PCT/EP2022/075402 patent/WO2023041524A2/en not_active Ceased
- 2022-09-13 AR ARP220102483A patent/AR127054A1/es unknown
-
2023
- 2023-06-26 US US18/341,437 patent/US12077578B2/en active Active
-
2024
- 2024-03-13 CL CL2024000753A patent/CL2024000753A1/es unknown
- 2024-07-15 US US18/773,301 patent/US20250084156A1/en active Pending
- 2024-07-16 US US18/774,629 patent/US12351624B2/en active Active
- 2024-07-16 US US18/774,608 patent/US12358974B2/en active Active
- 2024-07-16 US US18/774,646 patent/US12358975B2/en active Active
- 2024-12-03 CL CL2024003713A patent/CL2024003713A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024534947A5 (https=) | ||
| JP7080263B2 (ja) | 高濃度の抗ｖｅｇｆ抗体を含有する安定状態のタンパク質溶液製剤 | |
| US20230047111A1 (en) | Pharmaceutical formulations of tnf-alpha antibodies | |
| ES2986900T3 (es) | Formulaciones de anticuerpos anti-cd3 | |
| JP2024099682A5 (https=) | ||
| IL311344A (en) | Preparations and methods for the treatment of synoclinopathies | |
| JP2017160208A5 (https=) | ||
| JP2020506924A5 (https=) | ||
| CN106061468B (zh) | 包含TNFR和Fc区的融合蛋白的液体制剂 | |
| RU2018107725A (ru) | Стабильный состав на основе антитела к ifnar1 | |
| TWI857996B (zh) | 含高濃度抗ｖｅｇｆ抗體之蛋白質溶液配製物 | |
| JP2024503265A5 (https=) | ||
| FI3576788T3 (fi) | Matalan ph-arvon omaava farmaseuttinen koostumus, joka käsittää t-soluihin sitoutuvia vasta-ainekonstrukteja | |
| JP7398958B2 (ja) | 安定的抗ｏｓｍｒ抗体製剤 | |
| JP2022513684A5 (https=) | ||
| JP2020510079A (ja) | 抗ＴＮＦα抗体の液状製剤 | |
| JP2015535237A (ja) | Ｔｎｆｒ：ｆｃ融合プロテインの安定な医薬組成物 | |
| US20220370364A1 (en) | High concentration formulations of anti-csf1 and anti-csf1r antibodies | |
| JP2018532693A5 (https=) | ||
| JP2018536650A5 (https=) | ||
| JP2018501311A (ja) | 液体医薬組成物 | |
| RU2024106395A (ru) | Композиции и способы для лечения синуклеинопатий | |
| TWI775827B (zh) | 水性製劑及裝入注射器之水性製劑以及抗體蛋白去凝集劑及抗體蛋白去凝集方法 | |
| IL292493B1 (en) | Stable aqueous anti-TFPI antibody formulation | |
| TWI887362B (zh) | 抗內皮脂肪酶抗體之配製物 |